Press Releases-SINOVAC: Supply Vaccines to Eliminate Human Diseases-page1

Company
Innovation
Products

News
Investors
Careers
- Our Talent
中文 EN
Contact Us

Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

联系我们

当前地点：

EN

选择地点：

中文
EN

Home
Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

中文
EN

Press Releases

ALL YEAR

All
YEAR 2024
YEAR 2023
YEAR 2022
YEAR 2021
YEAR 2020
YEAR 2019
YEAR 2018
YEAR 2017
YEAR 2016
YEAR 2015
YEAR 2014
YEAR 2013
YEAR 2012
YEAR 2011
YEAR 2010
YEAR 2009
YEAR 2008
YEAR 2007
YEAR 2006
YEAR 2005

2019/12/27

Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
2019/11/15

Sinovac Reports Unaudited Third Quarter 2019 Financial Results
2019/08/15

Sinovac Reports Unaudited Second Quarter 2019 Financial Results
2019/07/10

Sinovac Reports Unaudited First Quarter 2019 Financial Results
2019/04/29

Sinovac Reports Unaudited Second Half of 2018 Financial Results and Files 2018 Annual Report on Form 20-F
2019/04/16

Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the JID

Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in The Journal of Infectious DiseasesThe Sinovac-developed sIPV demonstrates
2019/04/13

Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
2019/03/08

Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
2019/02/22

Sinovac Determines Trigger Event Occurred Under Rights Agreement

Previous page1Next page Go to No.

Follow Us

© SINOVAC All rights reserved